A one health approach to hypertrophic cardiomyopathy

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Hypertrophic cardiomyopathy (HCM†) is the most common inherited cardiac disease in humans and results in significant morbidity and mortality. Research over the past 25 years has contributed enormous insight into this inherited disease particularly in the areas of genetics, molecular mechanisms, and pathophysiology. Our understanding continues to be limited by the heterogeneity of clinical presentations with various genetic mutations associated with HCM. Transgenic mouse models have been utilized especially studying the genotypic and phenotypic interactions. However, mice possess intrinsic cardiac and hemodynamic differences compared to humans and have limitations preventing their direct translation. Other animal models of HCM have been studied or generated in part to overcome these limitations. HCM in cats shows strikingly similar molecular, histopathological, and genetic similarities to human HCM, and offers an important translational opportunity for the study of this disease. Recently, inherited left ventricular hypertrophy in rhesus macaques was identified and collaborative investigations have been conducted to begin to develop a non-human primate HCM model. These naturally-occurring large-animal models may aid in advancing our understanding of HCM and developing novel therapeutic approaches to this disease. This review will highlight the features of HCM in humans and the relevant available and developing animal models of this condition.

Original languageEnglish (US)
Pages (from-to)433-448
Number of pages16
JournalYale Journal of Biology and Medicine
Volume90
Issue number3
StatePublished - Sep 1 2017

Fingerprint

Hypertrophic Cardiomyopathy
Health
Animals
Animal Models
Hemodynamics
Molecular Biology
Left Ventricular Hypertrophy
Macaca mulatta
Primates
Transgenic Mice
Heart Diseases
Cats
Morbidity
Mutation
Mortality
Research

Keywords

  • Animal models
  • Cardiomyopathy
  • Familial hypertrophic cardiomyopathy
  • Genetics
  • Left ventricular hypertrophy

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

A one health approach to hypertrophic cardiomyopathy. / Ueda, Yu; Stern, Joshua A.

In: Yale Journal of Biology and Medicine, Vol. 90, No. 3, 01.09.2017, p. 433-448.

Research output: Contribution to journalReview article

@article{0eafa8c549aa48b48853f68f9daf09b8,
title = "A one health approach to hypertrophic cardiomyopathy",
abstract = "Hypertrophic cardiomyopathy (HCM†) is the most common inherited cardiac disease in humans and results in significant morbidity and mortality. Research over the past 25 years has contributed enormous insight into this inherited disease particularly in the areas of genetics, molecular mechanisms, and pathophysiology. Our understanding continues to be limited by the heterogeneity of clinical presentations with various genetic mutations associated with HCM. Transgenic mouse models have been utilized especially studying the genotypic and phenotypic interactions. However, mice possess intrinsic cardiac and hemodynamic differences compared to humans and have limitations preventing their direct translation. Other animal models of HCM have been studied or generated in part to overcome these limitations. HCM in cats shows strikingly similar molecular, histopathological, and genetic similarities to human HCM, and offers an important translational opportunity for the study of this disease. Recently, inherited left ventricular hypertrophy in rhesus macaques was identified and collaborative investigations have been conducted to begin to develop a non-human primate HCM model. These naturally-occurring large-animal models may aid in advancing our understanding of HCM and developing novel therapeutic approaches to this disease. This review will highlight the features of HCM in humans and the relevant available and developing animal models of this condition.",
keywords = "Animal models, Cardiomyopathy, Familial hypertrophic cardiomyopathy, Genetics, Left ventricular hypertrophy",
author = "Yu Ueda and Stern, {Joshua A}",
year = "2017",
month = "9",
day = "1",
language = "English (US)",
volume = "90",
pages = "433--448",
journal = "The Yale journal of biology and medicine",
issn = "0044-0086",
publisher = "Yale Journal of Biology and Medicine Inc.",
number = "3",

}

TY - JOUR

T1 - A one health approach to hypertrophic cardiomyopathy

AU - Ueda, Yu

AU - Stern, Joshua A

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Hypertrophic cardiomyopathy (HCM†) is the most common inherited cardiac disease in humans and results in significant morbidity and mortality. Research over the past 25 years has contributed enormous insight into this inherited disease particularly in the areas of genetics, molecular mechanisms, and pathophysiology. Our understanding continues to be limited by the heterogeneity of clinical presentations with various genetic mutations associated with HCM. Transgenic mouse models have been utilized especially studying the genotypic and phenotypic interactions. However, mice possess intrinsic cardiac and hemodynamic differences compared to humans and have limitations preventing their direct translation. Other animal models of HCM have been studied or generated in part to overcome these limitations. HCM in cats shows strikingly similar molecular, histopathological, and genetic similarities to human HCM, and offers an important translational opportunity for the study of this disease. Recently, inherited left ventricular hypertrophy in rhesus macaques was identified and collaborative investigations have been conducted to begin to develop a non-human primate HCM model. These naturally-occurring large-animal models may aid in advancing our understanding of HCM and developing novel therapeutic approaches to this disease. This review will highlight the features of HCM in humans and the relevant available and developing animal models of this condition.

AB - Hypertrophic cardiomyopathy (HCM†) is the most common inherited cardiac disease in humans and results in significant morbidity and mortality. Research over the past 25 years has contributed enormous insight into this inherited disease particularly in the areas of genetics, molecular mechanisms, and pathophysiology. Our understanding continues to be limited by the heterogeneity of clinical presentations with various genetic mutations associated with HCM. Transgenic mouse models have been utilized especially studying the genotypic and phenotypic interactions. However, mice possess intrinsic cardiac and hemodynamic differences compared to humans and have limitations preventing their direct translation. Other animal models of HCM have been studied or generated in part to overcome these limitations. HCM in cats shows strikingly similar molecular, histopathological, and genetic similarities to human HCM, and offers an important translational opportunity for the study of this disease. Recently, inherited left ventricular hypertrophy in rhesus macaques was identified and collaborative investigations have been conducted to begin to develop a non-human primate HCM model. These naturally-occurring large-animal models may aid in advancing our understanding of HCM and developing novel therapeutic approaches to this disease. This review will highlight the features of HCM in humans and the relevant available and developing animal models of this condition.

KW - Animal models

KW - Cardiomyopathy

KW - Familial hypertrophic cardiomyopathy

KW - Genetics

KW - Left ventricular hypertrophy

UR - http://www.scopus.com/inward/record.url?scp=85030257342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030257342&partnerID=8YFLogxK

M3 - Review article

C2 - 28955182

AN - SCOPUS:85030257342

VL - 90

SP - 433

EP - 448

JO - The Yale journal of biology and medicine

JF - The Yale journal of biology and medicine

SN - 0044-0086

IS - 3

ER -